Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02564744
Title Study to Evaluate the Efficacy and Tolerability Debio 1562 in Combination With Rituximab in Patients With Relapsed and/or Refractory DLBCL and Other Forms of NHL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Debiopharm International SA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | BEL


No variant requirements are available.